| Issue | Title | |
| Vol 14, No 3 (2013) | The utility of a model-based cost-effectiveness analysis of degarelix versus leuprolide in the therapy of hormone-dependent advanced prostate cancer | Abstract HTML PDF |
| Massimo Perachino, Mario Eandi | ||
| Vol 20, No 1 (2019) | The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis | Abstract HTML PDF |
| Paolo Angelo Cortesi, Damiano Paolicelli, Marco Capobianco, Paolo Cozzolino, Lorenzo Giovanni Mantovani | ||
| Vol 10, No 2 (2009) | Theory and practice of the Health Technology Assessment in countries with a predominant public health service | Details PDF |
| Mario Eandi | ||
| Vol 26, No 1 (2025) | Therapeutic Journey and Economic Burden of Patients with Myasthenia Gravis in Italy: Results of a Real-World Analysis | Abstract HTML PDF |
| Valentina Perrone, Stefania Mazzoni, Maria Cappuccilli, Margherita Andretta, Marcello Bacca, Antonietta Barbieri, Fausto Bartolini, Alessandro Chinellato, Andrea Ciaccia, Alberto Costantini, Francesco De Vita, Stefania Dell'Orco, Fulvio Ferrante, Simona Gentile, Stefano Grego, Daniela Mancini, Marzia Mensurati, Rossella Moscogiuri, Romina Pagliaro, Nicola Petragnani, Cataldo Procacci, Davide Re, Fiorenzo Santoleri, Michele Giuseppe Tari, Loredana Ubertazzo, Carlo Giuseppe Antozzi, Luca Degli Esposti | ||
| Vol 7, No 4 (2006) | Tigecycline: a review of the literature | Abstract PDF |
| Mario Venditti, Maria Elena Pompeo, Flavia Fabi | ||
| Vol 12, No 2 (2011) | Tiotropium bromide in the routine care of GOLD stage II COPD patients: a pharmaeconomic evaluation | Abstract HTML PDF |
| Orietta Zaniolo, Michela Carsi, Sergio Iannazzo | ||
| Vol 11, No 1 (2010) | Tiotropium in COPD: clinical outcomes and economic evidence | Abstract PDF |
| Orietta Zaniolo, Viola Sacchi, Roberto W. Dal Negro | ||
| Vol 13, No 2S (2012) | Toscana | Abstract HTML PDF |
| Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni | ||
| Vol 9, No 1S (2008) | Toscana | Abstract PDF |
| Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi | ||
| Vol 2, No 1 (2001) | Traiettorie tecniche e Metodologia QWERTY: come si applicano alle innovazioni farmaceutiche | Abstract PDF |
| Marina Altagracia, Mario Cimoli, Jaime Kravzov, Rafael Castillo, Ofelia Espejo, Albert I. Wertheimer | ||
| Vol 5, No 3 (2004) | Tramadolo: profilo farmacologico, terapeutico e farmacoeconomico | Abstract PDF |
| Loredana Serpe, Lorenzo Pradelli, Mario Eandi | ||
| Vol 4, No 1 (2003) | Trattamento con etanercept dei soggetti con artrite reumatoide in Italia: considerazioni economiche | Abstract PDF |
| Lorenzo G. Mantovani | ||
| Vol 14, No 1 (2013) | Treatment cost of metastatic colon cancer in Turkey | Abstract HTML PDF |
| Guvenc Kockaya, Mine Polat, Albert Wertheimer, Ahmet Ozet, Simten Malhan, İsmail Mert Vural, Akif Akbulat, Guven Artıran, Hakkı Gursoz, Saim Kerman | ||
| Vol 20, No 1 (2019) | Treatments of Advanced Non‑Small Cell Lung Cancer (NSCLC) in an Italian Center: Drug Utilization and the Treatment Costs of Innovative Drugs | Abstract HTML PDF |
| Francovito Piantedosi, Raffaela Cerisoli, Ciro Battiloro, Francesca Andreozzi, Fabiana Vitiello, Marina Gilli, Valeria De Marino, Antonietta Letizia, Antonella Bianco, Ivana Caprice, Adele Savoia, Adriano Cristinziano, Giorgia Smeraglio, Danilo Rocco | ||
| Vol 10, No 4 (2009) | Trends in prescribing and persistence with antihypertensive therapy: results of the study PAPEETE (Population-based Analysis of Persistence and Economics of treatment with telmisartan) study | Abstract PDF |
| Francesco Vittorio Costa | ||
| Vol 13, No 2S (2012) | Trento | Abstract HTML PDF |
| Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni | ||
| Vol 9, No 1S (2008) | Trento | Abstract PDF |
| Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi | ||
| Vol 13, No 2S (2012) | Umbria | Abstract HTML PDF |
| Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni | ||
| Vol 9, No 1S (2008) | Umbria | Abstract PDF |
| Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi | ||
| Vol 1, No 2 (2000) | Una checklist per la gestione dei costi nel trattamento dell’HIV | Abstract PDF |
| Vasilisa Sazonov, Uros Urleb, Albert L. Wertheimer | ||
| Vol 5, No 4 (2004) | Una valutazione economica di citrato di fentanile ad assorbimento orale (Actiq®) per la terapia del dolore in pazienti affetti da cancro | Abstract PDF |
| C. Lucioni, S. Mazzi | ||
| Vol 3, No 4 (2002) | Unita di consumo dei farmaci e valutazioni farmacoeconomiche: uso e misuso di DDD e PDD | Abstract PDF |
| Mario Eandi | ||
| Vol 9, No 4 (2008) | Usefulness and limitation of DDD and PDD analyses. 12 months of solid oral antipsychotics prescribing data for the NHS-reimbursed treatment of schizophrenia in Italy | Abstract PDF |
| Lorenzo Pradelli | ||
| Vol 16, No 3 (2015) | Using Patient-Reported Outcomes to Include the Patient in Research, Care, and Quality | Details HTML PDF |
| Priya Gaur, Nikita Jeswani, Nelly Ganesan | ||
| Vol 3, No 3 (2002) | Utilità e costo/efficacia del dinoprostone in ostetricia | Abstract PDF |
| Mario Eandi, Lorenzo Pradelli, Chiara Benedetto | ||
| Vol 18, No 1 (2017) | Utilization patterns of complementary and alternative medicine in Australia, Canada and the United States: popularity of dietary supplements, mind-body and manipulative therapies | Details HTML PDF |
| Marina Luketina Sunjka, Ana Pejcic, Mihajlo Jakovljevic | ||
| Vol 13, No 2S (2012) | Valle d’Aosta | Abstract HTML PDF |
| Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni | ||
| Vol 9, No 1S (2008) | Valle d’Aosta | Abstract PDF |
| Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi | ||
| Vol 12, No 1S (2011) | Valsartan: come versatilità e tollerabilità possono contribuireal contenimento della spesa sanitaria | Abstract PDF |
| Francesco Vittorio Costa | ||
| Vol 13, No 4 (2012) | Value of drug or valuable drug: a point of view issue | Details HTML PDF |
| Francesca Patarnello | ||
| Vol 6, No 4 (2005) | Valutazione clinica e metabolica dell’impiego dell’insulina Lispro in pazienti con diabete mellito scompensato | Abstract PDF |
| Antonio Uneddu, Tito Antonio Paolini | ||
| Vol 2, No 4 (2001) | Valutazione dei costi di trattamento dei disturbi psicotici con olanzapina, risperidone e neurolettici tipici di un DSM italiano | Abstract PDF |
| I. Rossi, L. Guidi | ||
| Vol 12, No 2S (2011) | Valutazione dei processi assistenziali e del carico economico dei soggetti con ospedalizzazione incidente di infarto acuto del miocardio mediante il Data Warehouse DENALI | Abstract PDF |
| Lorenzo G. Mantovani, Carla Fornari, Fabiana Madotto, Michele A. Riva, Luca Merlino, Virginio Chiodini, Giancarlo Cesana | ||
| Vol 4, No 1 (2003) | Valutazione del turn over dei farmaci antiretrovirali in particolare da IP a NNRTI | Abstract PDF |
| Sergio Sabbatani, Raffaella Cesari, Emanuela Pipitone, Francesco Chiodo | ||
| Vol 2, No 2 (2001) | Valutazione dell’impatto delle politiche del prezzo di riferimento sul mercato degli H2-antagonisti nella British Columbia, Canada | Abstract PDF |
| Lutchmie Narine, Mahil Senathirajah, Tina Smith, Albert I. Wertheimer | ||
| Vol 14, No 1 (2013) | Valutazione di efficienza nella somministrazione dell’ormone della crescita (GH) | Abstract HTML PDF |
| Federico Spandonaro, Letizia Mancusi | ||
| Vol 6, No 4 (2005) | Valutazione economica dei costi associati al trattamento di pazienti in ossigenoterapia a lungo termine, con o senza monitoraggio telemetrico domiciliare | Abstract PDF |
| Roberto Ravasio, Roberto W. Dal Negro, Carlo Lucioni | ||
| Vol 8, No 2S (2007) | Valutazione economica delle terapie farmacologiche | Details PDF |
| Lorenzo G. Mantovani, Simona Cammarota | ||
| Vol 8, No 2S (2007) | Valutazione economica dello studio AVERT | Abstract PDF |
| Simona De Portu, Simona Cammarota, Enrica Menditto, Lorenzo G. Mantovani | ||
| Vol 8, No 2S (2007) | Valutazione economica dello studio CARDS | Abstract PDF |
| Simona de Portu, Enrica Menditto, Lorenzo G. Mantovani | ||
| Vol 12, No 2S (2011) | Valutazione economica dello studio CARDS: un aggiornamento | Abstract PDF |
| Simona de Portu, Sabato Montella, Paolo Cortesi, Enrica Menditto, Lorenzo G. Mantovani | ||
| Vol 8, No 2S (2007) | Valutazione economica dello studio IDEAL | Abstract PDF |
| Enrica Menditto, Anna Citarella | ||
| Vol 8, No 2S (2007) | Valutazione economica dello studio MIRACL | Abstract PDF |
| Simona De Portu, Sabato Montella, Simona Cammarota, Lorenzo G. Mantovani | ||
| Vol 8, No 2S (2007) | Valutazione economica dello studio PROVE-IT | Abstract PDF |
| Lorenzo G. Mantovani, Sabato Montella, Anna Citarella, Simona De Portu | ||
| Vol 8, No 2S (2007) | Valutazione economica dello studio TNT | Abstract PDF |
| Lorenzo G. Mantovani, Sabato Montella, Anna Citarella, Simona De Portu | ||
| Vol 4, No 2 (2003) | Valutazione economica di Infliximab (Remicade®) vs Etanercept (Enbrel®) nel trattamento dell’artrite reumatoide | Abstract PDF |
| G. L. Colombo, A. Muzio, A. Longhi | ||
| Vol 6, No 4 (2005) | Valutazione farmacoeconomica della prevenzione con picotamide vs acido acetilsalicilico dei pazienti diabetici con vasculopatia periferica | Abstract PDF |
| Sergio Iannazzo, Lorenzo Pradelli, Mario Eandi | ||
| Vol 4, No 1 (2003) | Valutazione farmacoeconomica dell’uso di tramadolo vs ketorolac nella gestione del dolore postoperatorio | Abstract PDF |
| Lorenzo G. Mantovani | ||
| Vol 2, No 3 (2001) | Valutazione farmacoeconomica di una casistica di pazienti con riacutizzazione di bronchite cronica | Abstract PDF |
| M. Liconti, M. Polimeni, C. Filloramo, F. Reale | ||
| Vol 12, No 2S (2011) | Valutazioni economiche di atorvastatina in prevenzione secondaria: un aggiornamento | Abstract PDF |
| Simona de Portu, Sabato Montella, Paolo Cortesi, Enrica Menditto, Simona Cammarota, Anna Citarella, Lorenzo G. Mantovani | ||
| Vol 18, No 1 (2017) | Varenicline treatment for smoking cessation in high risk patients: a budget impact analysis | Abstract HTML PDF |
| Federico Spandonaro, Letizia Mancusi, Barbara Polistena | ||
| Vol 13, No 2S (2012) | Veneto | Abstract HTML PDF |
| Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni | ||
| Vol 9, No 1S (2008) | Veneto | Abstract PDF |
| Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi | ||
| Vol 14, No 3 (2013) | Venous thrombo-embolism (VTE) prevention of patients undergoing total hip and knee replacement: budget impact analysis of apixaban in Italy | Abstract HTML PDF |
| Lorenzo Giovanni Mantovani, Giovanni Di Minno, Gianluca Furneri | ||
| Vol 15, No 4 (2014) | Venous tromboembolism treatment: budget impact analysis of rivaroxaban in Italy | Abstract HTML PDF |
| Daniela Paola Roggeri, Alessandro Roggeri, Vittorio Pengo | ||
| Vol 13, No 2 (2012) | What are key determinants of hospital admissions, readmission rate and day case rate within the South African medical schemes population? | Abstract HTML PDF |
| Nondumiso Gugu Khumalo, Michael Willie, Evelyn Thsehla | ||
| Vol 8, No 2 (2007) | Which future for pharmacoeconomics in Italy? | Details PDF |
| Mario Eandi | ||
| Vol 17, No 2S (2016) | [Budget impact analysis for peginterferon beta-1a in relapsing remitting multiple sclerosis in Italy] | Abstract HTML PDF |
| Sergio Iannazzo, Laura Santoni, Cecilia Saleri, Elisa Puma, Giulia Vestri, Luigi Giuliani, Diego Centonze, Pier Luigi Canonico | ||
| Vol 17, No 1 (2016) | [Budget impact analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy] | Abstract HTML PDF |
| Gianluca Furneri, Chiara Marchesi, Laura Santoni | ||
| Vol 17, No 1 (2016) | [Budget impact analysis of empagliflozin for the treatment of type 2 diabetes in Italy] | Abstract HTML PDF |
| Sergio Iannazzo, Edoardo Mannucci, Lorenzo Mantovani | ||
| Vol 17, No 2 (2016) | [Budget impact analysis of idarucizumab for the management of patients treated with dabigatran in emergency / urgent situations in Italy] | Abstract HTML PDF |
| Andrea Belisari, Sergio Iannazzo, Giuseppe Di Pasquale, Claudio Fresco, Lorenzo Giovanni Mantovani, Maria Pia Ruggeri, Danilo Toni, Raffaele Landolfi | ||
| Vol 23, No 1 (2022) | [Budget Impact Analysis of the Adjuvanted Quadrivalent Influenza Vaccine in the Elderly in Italy] | Abstract HTML PDF |
| Vincenzo Baldo, Marco Bellone | ||
| Vol 24, No 1 (2023) | [Burden of Short Bowel Syndrome in Italy: Direct and Indirect Costs and Quality of Life] | Abstract HTML PDF |
| Francesco Saverio Mennini, Chiara Bini, Martina Paoletti, Andrea Marcellusi, Paolo Sciattella, Raffaella Viti, Lucrezia Amoroso, Laura Fioravanti, Gennaro Di Martino, Angela Ragonese, Riccardo Caccialanza, Lorenzo Norsa, Antonella Diamanti, Loris Pironi | ||
| Vol 17, No 3S (2016) | [Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market] | Abstract HTML PDF |
| Lorenzo Pradelli, Paolo Ascierto | ||
| Vol 25, No 1 (2024) | [Cost per Responder Analysis of Filgotinib in Patients Suffering from Ulcerative Colitis] | Abstract HTML PDF |
| Massimiliano Povero, Luca Castello, Lorenzo Pradelli, Elena Visentin | ||
| Vol 17, No 2 (2016) | [Cost-effectiveness analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy] | Abstract HTML PDF |
| Gianluca Furneri, Laura Santoni, Chiara Marchesi, Sergio Iannazzo, Paolo Angelo Cortesi, Achille Patrizio Caputi, Lorenzo Giovanni Mantovani | ||
| Vol 24, No 1 (2023) | [Cost-Effectiveness Analysis of Maribavir in Patients with Post-Transplant Cytomegalovirus Infection or Disease that are Refractory or Resistant to Conventional Therapy] | Abstract HTML PDF |
| Andrea Marcellusi, Chiara Bini, Simone Corinti, Laura Fioravanti, Laura Dalla Vedova, Stacey L. Amorosi, Tam De Lacey, Emtiyaz Chowdhury, Francesco Saverio Mennini | ||
| Vol 16, No 4 (2015) | [Cost-effectiveness analysis of ocriplasmin in the treatment of vitreomacular traction in Italy] | Abstract HTML PDF |
| Lucia Sara D'Angiolella, Riccardo Miglietta, Francesco Bandello, Stanislao Rizzo, Lorenzo Giovanni Mantovani | ||
| Vol 17, No 2S (2016) | [Cost-effectiveness analysis of peginterferon beta-1a in Italian relapsing remitting multiple sclerosis management] | Abstract HTML PDF |
| Sergio Iannazzo, Laura Santoni, Cecilia Saleri, Elisa Puma, Giulia Vestri, Luigi Giuliani, Pier Luigi Canonico, Diego Centonze | ||
| Vol 17, No 2 (2016) | [Cost-minimization analysis of replacement therapy in the treatment of von Willebrand disease] | Abstract HTML PDF |
| Giancarlo Castaman | ||
| Vol 23, No 1 (2022) | [Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy] | Abstract HTML PDF |
| Elena Galli, Maria Paola Pedone, Miryana Dobreva, Rossella Bitonti, Roberta Di Turi | ||
| Vol 25, No 1 (2024) | [Enhanced Influenza Vaccines Under Review by the ECDC and the Latest Scientific Literature] | Details HTML PDF |
| Pier Luigi Lopalco | ||
| Vol 25, No 1 (2024) | [Implantation of Reveal LINQ in Different Italian Scenarios: How to Further Improve?] | Abstract HTML PDF |
| Gaetano Senatore, Emilio Di Lorenzo, Orietta Zaniolo, Giovanni Liuzzi | ||
| Vol 18, No 1 (2017) | [In reference to "Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”] | Details HTML PDF |
| Matteo Ferrario, Giovanni Giuliani | ||
| Vol 17, No 2 (2016) | [Kovaltry® for the replacement therapy in patients with Hemophilia A] | Abstract HTML PDF |
| Daniela Paola Roggeri, Alessio Colombo, Alessandro Roggeri | ||
| Vol 24, No 1S (2023) | [Measurement-Based Procurement Approach for Biosimilars in Italy: A Position Paper] | Abstract HTML PDF |
| Arturo Cavaliere, Francesco Saverio Mennini, Marcello Pani, Paolo Gennaro Torrico, Salvatore Torrisi | ||
| Vol 18, No 1S (2017) | [Nintedanib for the treatment of idiopathic pulmonary fibrosis in Italy] | Abstract HTML PDF |
| Andrea Belisari, Daria Bettoni, Paolo Angelo Cortesi, Lucia Sara D'Angiolella, Lorenzo Giovanni Mantovani, Gerardo Miceli Sopo, Marino Nonis | ||
| Vol 17, No 3 (2016) | [Organizational and financial aspects of the introduction of Botox® in the clinical diagnostic therapeutic process of chronic migraine at a Local Health Unit in Italy] | Abstract HTML PDF |
| Francesca Cioffi, Marco Oradei, Rosanna Cerbo, Vittorio Di Pietro, Giovanna Riccioni, Gianni Pardhanani, Eleonora Capannini, Michele Basile | ||
| Vol 17, No 2S (2016) | [Pegylated interferon beta-1a on the Italian market] | Abstract HTML PDF |
| Mario Eandi | ||
| Vol 17, No 2S (2016) | [Pegylation and interferons in multiple sclerosis] | Abstract HTML PDF |
| Diego Centonze, Elisa Puma, Cecilia Saleri, Giulia Vestri, Sergio Iannazzo, Laura Santoni, Luigi Giuliani, Pier Luigi Canonico | ||
| Vol 18, No 1 (2017) | [Reply to Letter to the Editor in reference to " Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”] | Details HTML PDF |
| Lorenzo Pradelli, Paolo Ascierto | ||
| Vol 18, No 2S (2017) | [Tecfidera® (delayed-release dimethylfumarate) in the treatment of relapsing-remitting multiple sclerosis] | Abstract HTML PDF |
| Lorenzo Giovanni Mantovani, Gianluca Furneri, Paolo Angelo Cortesi, Maria Pia Amato, Achille Patrizio Caputi, Patrizio Piacentini, Alessandra Solari, Carlo Pozzilli, Giancarlo Comi | ||
| Vol 22, No 2S (2021) | [The Multidisciplinary Management of Type 2 Diabetes: an Integrated Care Model] | Abstract HTML PDF |
| Cesare Celeste Berra, Lorenzo Pradelli | ||
| Vol 18, No 1 (2017) | [Use of Kovaltry® in patients with Hemophilia A: clinical and economical aspects from the pivotal clinical trials] | Abstract HTML PDF |
| Lucia Sara D'Angiolella, Angelo Claudio Molinari, Paolo Angelo Cortesi, Antonio Coppola, Lorenzo Giovanni Mantovani | ||
| 401 - 484 of 484 Items | << < 1 2 3 4 5 | |
User
Font Size